Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAaaAW5vuE2hEElstl90r06sibT9dhT_4eb_p1wXy-CtQ#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _8 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "1.4" provenance.
- large_corpus.bel authoredBy _8 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _7 provenance.
- assertion hadPrimarySource 14587863 provenance.
- _7 wasQuotedFrom 14587863 provenance.
- _7 value "Retinoids, or vitamin A analogs, are among the most promising chemopreventive agents for breast cancer (Table I). Two classes of retinoid receptors, RARand RXR, bind retinoids and mediate transcriptional regulation of genes that control cellular proliferation, differentiation, and apoptosis (52). RXR is able to interact with many other factors such as vitamin D receptor (VDR), peroxisome proliferator- activator receptor (PPAR), thyroid hormone receptor, and COUP (Fig. 1). Retinoids have been shown to inhibit the growth and invasiveness of breast cancer cells in vitro and in vivo (" provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.